These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 6977086

  • 1. Isolation of three separate anaphylatoxins from complement-activated human serum.
    Hugli TE, Gerard C, Kawahara M, Scheetz ME, Barton R, Briggs S, Koppel G, Russell S.
    Mol Cell Biochem; 1981 Dec 04; 41():59-66. PubMed ID: 6977086
    [Abstract] [Full Text] [Related]

  • 2. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV, Reznikov IuP, Lobanova EV, Pimenova NS.
    Vestn Dermatol Venerol; 1989 Dec 04; (4):4-7. PubMed ID: 2788339
    [Abstract] [Full Text] [Related]

  • 3. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J.
    Methods Enzymol; 1988 Dec 04; 162():579-625. PubMed ID: 3265757
    [No Abstract] [Full Text] [Related]

  • 4. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
    Takematsu H, Ohkohchi K, Tagami H.
    Br J Dermatol; 1986 Jan 04; 114(1):1-6. PubMed ID: 3484631
    [Abstract] [Full Text] [Related]

  • 5. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ, Sumner H.
    Invest Ophthalmol Vis Sci; 1986 Aug 04; 27(8):1288-92. PubMed ID: 3488296
    [Abstract] [Full Text] [Related]

  • 6. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ, Das C, Bennett D, Terman DS.
    J Immunol; 1984 Aug 04; 133(2):1057-63. PubMed ID: 6610702
    [Abstract] [Full Text] [Related]

  • 7. Anaphylatoxin generation in multisystem organ failure.
    Heideman M, Hugli TE.
    J Trauma; 1984 Dec 04; 24(12):1038-43. PubMed ID: 6334754
    [Abstract] [Full Text] [Related]

  • 8. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
    Greer J.
    Enzyme; 1986 Dec 04; 36(1-2):150-63. PubMed ID: 3491754
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
    Huey R, Bloor CM, Kawahara MS, Hugli TE.
    Am J Pathol; 1983 Jul 04; 112(1):48-60. PubMed ID: 6859228
    [Abstract] [Full Text] [Related]

  • 10. Biochemistry and biology of anaphylatoxins.
    Hugli TE.
    Complement; 1986 Jul 04; 3(3):111-27. PubMed ID: 3542363
    [Abstract] [Full Text] [Related]

  • 11. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA, Steiger G, Paccaud JP.
    Clin Exp Immunol; 1986 May 04; 64(2):407-14. PubMed ID: 3488858
    [Abstract] [Full Text] [Related]

  • 12. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
    Hugli TE.
    Crit Rev Immunol; 1981 Feb 04; 1(4):321-66. PubMed ID: 7037298
    [No Abstract] [Full Text] [Related]

  • 13. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
    Wagner JL, Hugli TE.
    Anal Biochem; 1984 Jan 04; 136(1):75-88. PubMed ID: 6711816
    [Abstract] [Full Text] [Related]

  • 14. Characterization of human C4a anaphylatoxin.
    Gorski JP, Hugli TE, Müller-Eberhard HJ.
    J Biol Chem; 1981 Mar 25; 256(6):2707-11. PubMed ID: 6970745
    [Abstract] [Full Text] [Related]

  • 15. Anaphylatoxin formation in extracorporeal circuits.
    Chenoweth DE.
    Complement; 1986 Mar 25; 3(3):152-65. PubMed ID: 3492330
    [Abstract] [Full Text] [Related]

  • 16. Anaphylatoxin levels in human vitreous humor.
    Mondino BJ, Sidikaro Y, Sumner H.
    Invest Ophthalmol Vis Sci; 1988 Jul 25; 29(7):1195-8. PubMed ID: 3262096
    [Abstract] [Full Text] [Related]

  • 17. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
    Ohkohchi K, Takematsu H, Tagami H.
    Br J Dermatol; 1985 Aug 25; 113(2):189-96. PubMed ID: 3875363
    [Abstract] [Full Text] [Related]

  • 18. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S, Glovsky MM.
    J Allergy Clin Immunol; 1987 Jul 25; 80(1):24-32. PubMed ID: 3496373
    [Abstract] [Full Text] [Related]

  • 19. Relation between complement activation and susceptibility to decompression sickness.
    Ward CA, McCullough D, Fraser WD.
    J Appl Physiol (1985); 1987 Mar 25; 62(3):1160-6. PubMed ID: 3494726
    [Abstract] [Full Text] [Related]

  • 20. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S, Hugli TE, Andreatta RH, Hadding U, Bitter-Suermann D.
    Inflammation; 1981 Dec 25; 5(4):263-73. PubMed ID: 6976935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.